Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-038352
Filing Date
2013-07-30
Accepted
2013-07-30 16:53:03
Documents
1
Period of Report
2013-07-26

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c576523_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c576523_4x0.xml 4 3907
  Complete submission text file 0001209191-13-038352.txt   5500
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address
Grais Linda S (Reporting) CIK: 0001413306 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 13996516